Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enhanced mucosal immune responses and reduced viral load in the respiratory tract of ferrets to intranasal lipid nanoparticle-based SARS-CoV-2 proteins and mRNA vaccines.
Boley PA, Lee CM, Schrock J, Yadav KK, Patil V, Suresh R, Lu S, Feng MM, Hanson J, Channappanavar R, Kenney SP, Renukaradhya GJ. Boley PA, et al. Among authors: renukaradhya gj. J Nanobiotechnology. 2023 Feb 22;21(1):60. doi: 10.1186/s12951-023-01816-3. J Nanobiotechnology. 2023. PMID: 36814238 Free PMC article.
Correction: A split influenza vaccine formulated with a combination adjuvant composed of alpha-D-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs.
Patil V, Hernandez-Franco JF, Yadagiri G, Bugybayeva D, Dolatyabi S, Feliciano-Ruiz N, Schrock J, Hanson J, Ngunjiri J, HogenEsch H, Renukaradhya GJ. Patil V, et al. Among authors: renukaradhya gj. J Nanobiotechnology. 2022 Dec 23;20(1):539. doi: 10.1186/s12951-022-01741-x. J Nanobiotechnology. 2022. PMID: 36550477 Free PMC article. No abstract available.
Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization.
Hernandez-Franco JF, Yadagiri G, Patil V, Bugybayeva D, Dolatyabi S, Dumkliang E, Singh M, Suresh R, Akter F, Schrock J, Renukaradhya GJ, HogenEsch H. Hernandez-Franco JF, et al. Among authors: renukaradhya gj. Vaccines (Basel). 2023 Nov 7;11(11):1699. doi: 10.3390/vaccines11111699. Vaccines (Basel). 2023. PMID: 38006031 Free PMC article.
Characterization of the Efficacy of a Split Swine Influenza A Virus Nasal Vaccine Formulated with a Nanoparticle/STING Agonist Combination Adjuvant in Conventional Pigs.
Patil V, Hernandez-Franco JF, Yadagiri G, Bugybayeva D, Dolatyabi S, Feliciano-Ruiz N, Schrock J, Suresh R, Hanson J, Yassine H, HogenEsch H, Renukaradhya GJ. Patil V, et al. Among authors: renukaradhya gj. Vaccines (Basel). 2023 Nov 10;11(11):1707. doi: 10.3390/vaccines11111707. Vaccines (Basel). 2023. PMID: 38006039 Free PMC article.
Production and characterization of anti-porcine CXCL10 monoclonal antibodies.
Hailstock T, Dai C, Aquino J, Walker KE, Chick S, Manirarora JN, Suresh R, Patil V, Renukaradhya GJ, Sullivan YB, LaBresh J, Lunney JK. Hailstock T, et al. Among authors: renukaradhya gj. Cytokine. 2024 Feb;174:156449. doi: 10.1016/j.cyto.2023.156449. Epub 2023 Dec 22. Cytokine. 2024. PMID: 38141459
An intranasal vaccine comprising SARS-CoV-2 spike receptor-binding domain protein entrapped in mannose-conjugated chitosan nanoparticle provides protection in hamsters.
Tabynov K, Solomadin M, Turebekov N, Babayeva M, Fomin G, Yadagiri G, Renu S, Yerubayev T, Petrovsky N, Renukaradhya GJ, Tabynov K. Tabynov K, et al. Among authors: renukaradhya gj. Sci Rep. 2023 Jul 26;13(1):12115. doi: 10.1038/s41598-023-39402-0. Sci Rep. 2023. PMID: 37495639 Free PMC article.
Author Correction: An intranasal vaccine comprising SARS‑CoV‑2 spike receptor‑binding domain protein entrapped in mannose‑conjugated chitosan nanoparticle provides protection in hamsters.
Tabynov K, Solomadin M, Turebekov N, Babayeva M, Fomin G, Yadagiri G, Renu S, Yerubayev T, Petrovsky N, Renukaradhya GJ, Tabynov K. Tabynov K, et al. Among authors: renukaradhya gj. Sci Rep. 2023 Aug 1;13(1):12485. doi: 10.1038/s41598-023-39818-8. Sci Rep. 2023. PMID: 37528132 Free PMC article. No abstract available.
A recombinant Artemisia vulgaris pollen adjuvanted Art v 1 protein-based vaccine treats allergic rhinitis and bronchial asthma using pre- and co-seasonal ultrashort immunotherapy regimens in sensitized mice.
Babayeva M, Tabynov K, Nurpeisov T, Fomin G, Renukaradhya GJ, Petrovsky N, Tabynov K. Babayeva M, et al. Among authors: renukaradhya gj. Front Immunol. 2022 Nov 9;13:983621. doi: 10.3389/fimmu.2022.983621. eCollection 2022. Front Immunol. 2022. PMID: 36439113 Free PMC article.
110 results